Wenchun Jiang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Computational drug repositioning by virtually screening existing drugs for additional therapeutic usage could efficiently accelerate anticancer drug discovery. Herein, a library of 1447 Food and Drug Administration (FDA)-approved small molecule drugs was screened in silico for inhibitors of extracellular signal-regulated kinase 2 (ERK2). Then, in vitro(More)
  • 1